key: cord-0901854-49vjwxmn
authors: Nakabayashi, Takeru; Kawasaki, Yuki; Murashima, Koichiro; Omi, Kazuya; Yuhara, Satoshi
title: Evaluation of the effects of SARS-CoV-2 genetic mutations on diagnostic RT-PCR assays
date: 2021-01-20
journal: bioRxiv
DOI: 10.1101/2021.01.19.426622
sha: 18ad6a467878bcadb178d45c1422abba3c2344ed
doc_id: 901854
cord_uid: 49vjwxmn

Several mutant strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are emerging. Mismatch(es) in primer/probe binding regions would decrease the detection sensitivity of the PCR test, thereby affecting the results of clinical testing. In this study, we conducted an in silico survey on SARS-CoV-2 sequence variability within the binding regions of primer/probe published by the Japan National Institute of Infectious Diseases (NIID) and Centers for Disease Control and Prevention (CDC). In silico analysis revealed the presence of mutations in the primer/probe binding regions. We performed RT-PCR assays using synthetic RNAs containing the mutations and showed that some mutations significantly decreased the detection sensitivity of the RT-PCR assays. Our results highlight the importance of genomic monitoring of SARS-CoV-2 and evaluating the effects of mismatches on PCR testing sensitivity.

Coronavirus disease 2019 (COVID-19) pandemic is caused by the SARS-CoV-2 virus 33 (1), and the global number of cases has reached 63 million as of December 2020 (2). for Disease Control and Prevention (CDC) that has been widely used in Japan. 38 The primers and probes for RT-PCR are designed to detect the conserved region of the 39 SARS-CoV-2 RNA sequence. Hence, it is crucial to assess the impact of gene mutations 40 observed in primer/probe binding sites on the sensitivity of SARS-CoV-2 detection. 41 Several in silico surveys have shown the emergence of mutant strains that exhibit 42 mismatches in the primer/probe binding regions; however, these studies did not assess the 43 effect of such mutations on PCR testing (3, 4).

Here, we conducted an in silico survey of sequence variability within the binding regions 

The whole-genome sequence data of SARS-CoV-2 were downloaded from the GISAID 54 database (July 6, 2020) (5). Genome data with the total length comprising less than 29,000 55 bases and derived from non-human hosts were excluded (59,621 sequences in total). The 56 region spanning from 27,500th to 29,500th base pairs of each sequence containing the 57 amplification region was extracted, and the sequences that contained N in this region were 58 filtered out (47,836 sequences in total). We aligned the primer and probe sequences 59 developed by NIID and CDC (Table 1) In the present study, we conducted an in silico survey of mismatches in the binding 104 regions of primer/probe published by NIID and CDC, which are primarily used in Japan. 105 We also investigated the effects of SARS-CoV-2 genomic mutations on the detection 

Holmes 128 EC, Zhang YZ. 2020. A new coronavirus associated with human respiratory 129 disease in China

Implication of SARS-CoV-2 evolution in the 132 sensitivity of RT-qPCR diagnostic assays

Presence of mismatches between diagnostic PCR 135 assays and coronavirus SARS-CoV-2 genome

GISAID: global initiative on sharing all influenza data 137 -from vision to reality

Flexible sequence similarity searching with the FASTA3 139 program package

In silico re-141 assessment of a diagnostic RT-qPCR assay for universal detection of Influenza A 142 viruses